Summary
Response Genetics, Inc. Signs Amendment to Its Master Service Agreement With GlaxoSmithKline (GSK) as Preferred Provider of Genetic Testing Services. The sub-text is that GSK is preparing to "package" their targeted drugs with tests to identify the target!
Analysis
SYNERGY!! This is a win for GSK and a win for the entire genetic testing industry. Again, just the tip of an iceberg!
I told you so in prior posts!
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
